Association of Serum Lipoprotein-Associated Phospholipase A2 Level with Nonalcoholic Fatty Liver Disease

Date
2012
Author
ENC, Feruze Yilmaz
OZTURK, Oğuzhan
ULASOGLU, Celal
OZKANLI, Seyma
COLAK, Yaşar
SENATES, Ebubekir
Coskunpinar, Ender Mehmet
Sahin, Onder
Eren, Ayse
Oltulu, Yasemin Musteri
DOGANAY, Hamdi Levent
TUNCER, Ilyas
Metadata
Show full item record
Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is one of the most common causes of chronic liver disease, worldwide. Lipoprotein-associated phospholipase A2 (Lp-PLA2) was recently characterized as a novel inflammatory biomarker that is correlated with several components constituting the metabolic syndrome.
URI
http://hdl.handle.net/20.500.12627/152113
https://doi.org/10.1089/met.2011.0111
Collections